1, 2 FDA approval means its been found safe and effective for treating specific conditions in clinical trials
Abd-Rabou AA, Abdalla AM, Ali NA, Zoheir KM
Top Benefits: Supports sustainable weight management with average losses of up to 15-17% of total body weight in clinical studies Enhances satiety and portion control Promotes balanced blood sugar and metabolic health Dual-agonist injection that activates both GLP-1 and GIP receptors for enhanced appetite regulation, glucose balance, and fat metabolism
10.1001/jama.2018.3024 Summary Keywords semaglutide, tirzepatide, dulaglutide, liraglutide, GLP-1 (Glucagon-Like Peptide 1), HbA1c, type 2 diabetes mellitus, randomized controlled trials Citation Karimi MA, Gholami Chahkand MS, Dadkhah PA, Sheikhzadeh F, Yaghoubi S, Esmaeilpour Moallem F, Deyhimi MS, Arab Bafrani M, Shahrokhi M and Nasrollahizadeh A (2025) Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis